Tania Rivera-Hernández

Author

Also Known As

Peralta-Sánchez G, T. Rivera-Hernández, Tania Rivera Hernández, Tania Rivera-Hernandez, Tania Rivera-Hernández, Tania Rivera‐Hernandez

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland Griffith University The University of Melbourne Peter Doherty Institute QIMR Berghofer Medical Research Institute

About

Tania Rivera-Hernández is an author at The University of Queensland specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	487
2	Immunology	9	9	487
3	Allergy	3	3	85
4	Microbiology	3	3	322
5	Epidemiology	1	1	42

Tania Rivera-Hernández

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics Mark R. Davies, Liam McIntyre, Ankur Mutreja, Nature Genetics VaccinationReverse VaccinologyVaccine TargetImmunologyLarge-scale Comparative Genomics	2019	198
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines Anton P. J. Middelberg, Tania Rivera-Hernández, Nani Wibowo, Vaccine VaccinologyVaccinationLow-cost Virus-like ParticleVaccine DevelopmentVaccine Target	2011	85
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance Lisa Bohlmann, David M. P. De Oliveira, Ibrahim M. El‐Deeb, mBio	2018	79
An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model Tania Rivera-Hernández, Diane G. Carnathan, Scott Jones, mBio	2019	77
Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes Stephan Brouwer, Timothy C. Barnett, Diane Ly, Nature Communications	2020	71
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models Tania Rivera-Hernández, Manisha Pandey, Anna Henningham, mBio	2016	66
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study Joshua Osowicki, Kristy Azzopardi, Loraine Fabri, The Lancet Microbe	2021	57
Vaccine-Induced Th1-Type Response Protects against Invasive Group A <i>Streptococcus</i> Infection in the Absence of Opsonizing Antibodies Tania Rivera-Hernández, Mira Syahira Rhyme, Amanda J. Cork, mBio	2020	54
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis David M. P. De Oliveira, Lisa Bohlmann, Trent Conroy, Science Translational Medicine	2020	54
The contribution of non-human primate models to the development of human vaccines. Tania Rivera-Hernández, Diane G. Carnathan, Peter M. Moyle, PubMed VaccinationVaccine SafetyVaccinologyVaccine DevelopmentMedicine	2014	42

Page 1